Recent studies suggest that GLP-1 medications, known for their role in managing Type 2 diabetes and weight loss, may also help reduce cravings and substance use in addiction treatment. However, historical precedents raise questions about their effectiveness in real-world scenari…
Men's mental health is a pressing issue, with nearly 80% of suicides in the US attributed to men. Despite 95% of men prioritizing mental health, many do not receive adequate treat…
Recent research indicates that GLP-1 agonists, such as Ozempic, may not only aid in weight loss but also reduce cravings for addictive substances like alcohol. This effect is link…
A troubling trend in Nigeria reveals that children as young as nine are consuming alcohol, often introduced to it by family members and peers. This early exposure raises significa…
Experts highlight various symptoms experienced during sleep that could signal underlying health problems. Conditions such as sleep apnea, acid reflux, and sleepwalking are discuss…
Following their recent federal recognition, the Lumbee Tribe in North Carolina confronts significant health disparities, particularly in metabolic health. Despite the promise of f…
The Department of Veterans Affairs has initiated a clinical trial to assess the effectiveness of semaglutide, a GLP-1 drug typically used for diabetes and weight loss, in treating…
A recent study funded by the NIH has uncovered how newer oral GLP-1 drugs, including orforglipron and danuglipron, affect the brain's reward circuits in mice, potentially reducing…
Raye, the British singer-songwriter, reflects on her journey as an independent artist and the success of her hit song 'Where Is My Husband!', which has sold over 1.2 million copie…
Batarti Gabbard, the brother of former National Intelligence Director Tulsi Gabbard, has been charged with attempting to lure children to a hotel room in Waikiki, Hawaii. The inci…